The Effects of Targeting the Vaccinia Virus B5R Protein to the Endoplasmic Reticulum on Virus Morphogenesis and Dissemination  by Mathew, Elizabeth C. et al.
c
s
g
t
b
a
D
o
c
e
1
a
A
p
a
c
s
R
2
Virology 265, 131–146 (1999)
Article ID viro.1999.0023, available online at http://www.idealibrary.com onThe Effects of Targeting the Vaccinia Virus B5R Protein to the Endoplasmic Reticulum
on Virus Morphogenesis and Dissemination
Elizabeth C. Mathew,1 Christopher M. Sanderson,2 Ruth Hollinshead, Michael Hollinshead,
Rachel Grimley,3 and Geoffrey L. Smith4
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, United Kingdom
Received July 8, 1999; returned to author for revision July 29, 1999; accepted September 24, 1999
The consequence of redirecting the vaccinia virus (VV) B5R protein to the endoplasmic reticulum (ER) has been
investigated by the addition of an ER retrieval signal KKSL (K2X2) to the B5R C-terminus. This mutant B5R gene and a version
of the gene with the inactive ER retrieval sequence KKSLAL (K2X4) were inserted into the thymidine kinase locus of a VV
mutant lacking the B5R gene, vDB5R. Similar levels of B5R protein were made by each virus, but the B5R-K2X2 protein
remained sensitive to endoglycosidase H and colocalised with protein disulphide isomerase in the ER. In contrast, the
B5R-K2X4 protein colocalised with 1,4-galactosyltransferase in the trans-Golgi network. Electron microscopy revealed that
even when the B5R protein was redirected to the ER, intracellular mature virus particles were wrapped by cellular
membranes to form intracellular enveloped virus particles, although more incompletely wrapped particles were evident
compared with wild type. These intracellular enveloped virus particles were, however, unable to efficiently induce the
polymerisation of actin and the plaque size formed by vB5R-K2X2 was small. Nevertheless, the amount and specific infectivity
of EEV produced by vB5R-K2X2 were similar to those of wild type, despite the dramatic reduction in the amount of B5R protein
present in vB5R-K2X2 EEV. © 1999 Academic Press
Key Words: vaccinia virus; B5R protein; endoplasmic reticulum; actin tails; extracellular enveloped virus; electron micros-
copy; plaque size.
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Vaccinia virus (VV) is a complex DNA virus that repli-
ates in the cell cytoplasm and has a large double-
tranded DNA genome encoding approximately 200
enes (Moss, 1996). VV particles are large and complex:
he particles are 250 nm 3 350 nm, sufficiently large to
e seen easily with fluorescent microscopy (Cudmore et
l., 1995) and contain more than 100 proteins (Essani and
ales, 1979).
Virus morphogenesis commences in cytoplasmic foci
r factories, and two forms of infectious virus particle,
alled intracellular mature virus (IMV) and extracellular
nveloped virus (EEV), are produced (Appleyard et al.,
971). These virions have different biological properties
nd different roles in the virus life cycle (Boulter and
ppleyard, 1973; Payne and Kristensson, 1985; Vander-
lasschen et al., 1998). Morphogenesis begins with the
ppearance of virus crescents that are composed of lipid
1 Present address: MRC Immunochemistry Unit, Department of Bio-
hemistry, University of Oxford, OX1 3QU UK.
2 Present address: UK MRC Human Genome Mapping Project Re-
ource Centre, Hinxton, Cambridge, CB10 1SB UK.
3 Present address: IPC 865, Building 273, Discovery Biology, Central
esearch Pfizer Ltd., Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.
4 To whom reprint requests should be addressed. Fax: 44-1865-
p75501. E-mail: glsmith@molbiol.ox.ac.uk.
131nd protein. Early studies suggested that these struc-
ures contained a single lipid bilayer and were synthe-
ised de novo within the cytoplasm (Joklik and Becker,
964; Dales and Mosbach, 1968). Later, these structures
ere proposed to contain two lipid bilayers that were
erived from and continuous with host cell membranes
f the intermediate compartment between the endoplas-
ic reticulum (ER) and the Golgi complex (Sodeik et al.,
993). Recently, further electron microscopy has shown
hat these crescents, immature virus (IV) particles, and
MV particles contain only a single lipid bilayer (Hollins-
ead et al., 1999). Regardless of the origin and nature of
hese crescents, it is clear that once formed, they extend
o form noninfectious IV particles. After condensation of
he core and proteolytic processing of several capsid
roteins (Moss and Rosenblum, 1973), infectious IMV
articles are formed.
IMV particles represent the majority of infectious prog-
ny, and most remain inside the cell until cell lysis.
owever, some IMV particles are wrapped by a double
ayer of membrane (Ichihashi et al., 1971) derived from
he trans-Golgi network (TGN) (Hiller and Weber, 1985;
chmelz et al., 1994) or tubular endosomes (Tooze et al.,
993) to form intracellular enveloped virus (IEV). IEV
articles promote the polymerisation of actin tails on one
ide of the virion to create a growing tail that gives the
article motility (Cudmore et al., 1995). When an IEV
0042-6822/99 $30.00
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132 MATHEW ET AL.eaches the cell periphery, its outer membrane fuses
ith the plasma membrane to produce an enveloped
irus on the cell surface. This virion may remain attached
o the cell surface as cell-associated enveloped virus
CEV) (Blasco and Moss, 1991) or be released as EEV.
he proportion of enveloped virus that is retained (CEV)
r released (EEV) varies with different strains of VV
Payne, 1980) and is affected by several EEV-specific
roteins (see later).
Six VV genes have been found to encode EEV-specific
roteins: F13L (p37) (Hirt et al., 1986), A33R (gp22-28)
Roper et al., 1996), A34R (gp22-24) (Duncan and Smith,
992), A36R (p45–50) (Parkinson and Smith, 1994), A56R
gp86, the virus haemagglutinin) (Shida, 1986), and B5R
gp42) (Engelstad et al., 1992; Isaacs et al., 1992). The
unction of these proteins has been studied using virus
utants in which the virus gene is either mutated, de-
eted, or repressed. These studies have shown that
hese proteins have little effect on the formation of IMV.
owever, the proteins have different roles in the subse-
uent stages of morphogenesis. In the absence of B5R
Engelstad and Smith, 1993; Wolffe et al., 1993), F13L
Blasco and Moss, 1991), or A34R (Duncan and Smith,
992; McIntosh and Smith, 1996; Wolffe et al., 1997), the
rapping of IMV particles to form IEV is reduced or
bolished, and in the absence of A33R, there is an
ncreased proportion of virions in which the wrapping is
ncomplete (Roper et al., 1998). Consequently, the forma-
ion of actin tails by all of these viruses is reduced or
nhibited (Cudmore et al., 1995; Wolffe et al., 1997, 1998;
errera et al., 1998; Mathew et al., 1998; Roper et al.,
998; Sanderson et al., 1998; Ro¨ttger et al., 1999). The
36R (Parkinson and Smith, 1994) and A56R proteins
G. L. Smith, unpublished data) are not required for IEV
ormation, but A36R is needed for the polymerisation of
ctin tails (Sanderson et al., 1998; Wolffe et al., 1998;
o¨ttger et al., 1999). Thus the A36R deletion mutant is the
nly EEV mutant that makes IEV normally but no actin
ails, and this, together with the fact that the majority of
ts amino acids are in the cytosol (Ro¨ttger et al., 1999),
akes A36R the prime candidate for the initiation of actin
ail polymerisation. Many of the virus mutants lacking
EV proteins make small plaques (Blasco and Moss,
991; Duncan and Smith, 1992; Engelstad and Smith,
993; Wolffe et al., 1993; Parkinson and Smith, 1994;
oper et al., 1998), and there is a correlation between the
nability to make actin tails and a small plaque pheno-
ype. One exception is the virus lacking the four short
onsensus repeat (SCR) domains of B5R, which makes a
ormal-size plaque but does not form actin tails (Herrera
t al., 1998).
The roles of EEV proteins in EEV formation are vari-
ble. Loss of the F13L and B5R genes reduce EEV for-
ation approximately 10-fold (Blasco and Moss, 1991;
ngelstad and Smith, 1993; Wolffe et al., 1993), whereas
utation (Blasco et al., 1993) or deletion (McIntosh and tmith, 1996; Wolffe et al., 1997) of the A34R gene in-
reases EEV formation. In the latter case, the EEV levels
ncreased 25-fold but the EEV had a 5-fold reduced
pecific infectivity (McIntosh and Smith, 1996). Similarly,
emoval of all (Herrera et al., 1998) or parts (Mathew et
l., 1998) of the B5R extracellular domain increased EEV
ormation by 10- or more than 50-fold- respectively, but
hese virions have normal infectivity. Deletion of the A33R
r A36R genes has more modest effects on EEV forma-
ion, with a twofold to fourfold increase after the loss of
33R (Roper et al., 1998) and a threefold to fivefold
ecrease after the loss of A36R (Parkinson and Smith,
994).
The B5R gene encodes a 42-kDa glycoprotein that is
xpressed throughout infection (Engelstad et al., 1992;
saacs et al., 1992). In addition, there is a soluble, 35-kDa
5R protein of unknown function (Martinez-Pomares et
l., 1993). When expressed independently of vaccinia
irus infection, the B5R protein localises in the Golgi
omplex (Katz et al., 1997). The B5R protein affects virus
laque size, host range, and virulence (Takahashi-Nishi-
aki et al., 1991; Engelstad and Smith, 1993; Martinez-
omares et al., 1993; Wolffe et al., 1993; Stern et al., 1997).
ts extracellular domain shares amino acid similarity with
omplement control proteins (Goebel et al., 1990; Smith
t al., 1991; Takahashi-Nishimaki et al., 1991) and has
our SCRs that are typical of the regulators of comple-
ent activation superfamily. Despite this similarity, no
ole for the B5R protein in inhibiting complement activity
as been found (Vanderplasschen et al., 1998; M. Law
nd G. L. Smith, unpublished data). Mutagenesis of the
5R protein showed that deletion of one, two, or three
CR domains resulted in a small plaque phenotype but
he release of 50-fold more EEV of normal infectivity
Mathew et al., 1998). Deletion of all four SCRs produced
normal plaque size (Herrera et al., 1998). The trans-
embrane anchor sequence and short cytoplasmic do-
ain of B5R were sufficient to target a chimeric human
mmunodeficiency virus type 1 glycoprotein to the EEV
uter envelope (Katz et al., 1997), and loss of the short
ytoplasmic tail did not affect the function of the B5R
rotein (Lorenzo et al., 1999). Evidence for interactions
etween the B5R and A34R proteins has been presented
Ro¨ttger et al., 1999). These observations taken together
ith the failure of the B5R deletion mutant to wrap IMV
articles to form IEV suggested that B5R is a critical
rotein for initiation of the wrapping process and per-
aps the accumulation of other EEV proteins in the TGN.
In this report, we redirected the B5R protein to the ER
y the addition of an ER retrieval sequence (KKSL, K2X2)
Jackson et al., 1990, 1993) at the C-terminus. Similar
pproaches have been used to investigate the effect of
R localisation of herpes simplex virus glycoprotein H
Browne et al., 1996) and simian immunodeficiency virus
nvelope protein (Vincent et al., 1998). It was anticipatedhat either the relocation of B5R to the ER might prevent
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133TARGETING VACCINIA PROTEIN B5R TO THE ERhe formation of EEV due to a failure to wrap IMV parti-
les by membranes lacking the B5R protein (as for the
5R deletion mutant) or B5R in the ER might induce
rapping of IMV particles by ER membranes. In fact, the
etention of B5R in the ER did not prevent wrapping of
MV particles by the usual cellular membranes. Instead,
t resulted in a considerable reduction in actin tail for-
ation and plaque size and the production of EEV par-
icles at normal levels and infectivity despite the absence
f the B5R protein from these virions. The implications of
hese findings are discussed.
RESULTS
onstruction of recombinant VVs expressing
5R-K2X2 or B5R-K2X4
To evaluate the effect of redirecting the B5R protein to
he ER, two recombinant VVs were constructed. One of
hese had the ER retrieval sequence K2X2 (Jackson et al.,
990; 1993) attached to the extreme C-terminus of the
5R protein, whereas the other had an inactive version of
he ER retrieval sequence (K2X4) (Jackson et al., 1990;
993) at this position. Each of these B5R genes, under
he control of the B5R promoter, was inserted into the TK
ocus of vDB5R, a recombinant VV lacking the B5R gene
Engelstad and Smith, 1993), as described in Materials
nd Methods. As a control, a virus, vB5R/TK (Mathew et
l., 1998), that contained the wild-type (WT) B5R gene
nserted into the TK locus of vDB5R was analysed in
arallel.
The genomes of the vB5R-K2X2 and vB5R-K2X4 viruses
ere analysed by PCR and Southern blotting and found
o have the anticipated genome structures: namely, each
irus had the B5R ORF plus the anticipated C-terminal
otif inserted into the TK gene and retained a deletion in
he B5R gene at its natural locus (data not shown).
nalysis of B5R gene expression
To determine whether the mutant B5R proteins were
xpressed and at what level, cells were either mock-
nfected or infected with vDB5R, vB5R/TK, vB5R-K2X2, or
B5R-K2X4, and extracts from infected cells were anal-
sed by immunoblotting using a polyclonal anti-B5R an-
iserum (Fig. 1). A protein of 42 kDa was detected at
imilar levels in cells infected with vB5R/TK, vB5R-K2X2,
r vB5R-K2X4 but was absent in vDB5R- and mock-in-
ected cells. In the presence of tunicamycin, each protein
as reduced in size, as reported previously for the WT
5R protein (Mathew et al., 1998), but again the abun-
ance of the protein was equivalent in each case. As a
ontrol to show that the cells had been infected to a
imilar degree, the nitrocellulose membrane was
tripped and then reprobed with monoclonal antibody
MAb) AB1.1 directed against the D8L gene product (Par-
inson and Smith, 1994). Similar amounts of this protein Kere detected in all infected cells (lanes 3–10). Evidently,
he presence of the C-terminal short amino acid tags did
ot affect the size or steady-state level of the B5R protein.
he B5R-K2X2 protein is present in the ER
Endoglycosidase H (endoH) digests the high mannose
arbohydrate side chains of glycoproteins that have
een synthesized in the ER but that have not been
rocessed within the Golgi complex (Maley et al., 1989).
owever, after trimming of the mannose side chains and
ddition of complex sugars in the TGN, glycoproteins
ecome resistant to endoH digestion (Maley et al., 1989).
hus the sensitivity of a glycoprotein to endoH can be
sed to determine whether it has been transported
hrough the Golgi complex or is retained in the ER. If the
2X2 motif was functioning as anticipated, the B5R-K2X2
rotein would be expected to be retained in the ER and
ould remain sensitive to endoH digestion. To test this,
ells were infected with WT, vB5R/TK, vB5R-K2X2, or
B5R-K2X4 viruses and pulse-labeled with [
35S]methi-
nine and [35S]cysteine for 5 min at 6.5 h postinfection
p.i.). Cells were then chased with cold methionine and
ysteine for different lengths of time, immunoprecipitated
ith anti-B5R antiserum, incubated with or without
ndoH, and analysed by SDS–PAGE. For the WT and
B5R/TK viruses, the B5R protein was sensitive to diges-
ion by endoH immediately after pulse, but became re-
istant by 80 min of chase (Fig. 2). In contrast, the
5R-K2X2 protein remained sensitive to endoH digestion
hroughout this pulse-chase period, indicating it was
etained in the ER (Fig. 2). A much longer chase (6 h)
howed that a small proportion of the B5R-K2X2 protein
id become endoH resistant (data not shown). The B5R-
FIG. 1. Immunoblot showing the B5R protein synthesised by mutant
iruses. Extracts from mock-infected cells or cells infected with the
ndicated virus were prepared and immunoblotted as described in
aterials and Methods. In the upper panel, the B5R protein was
etected with rabbit anti-B5R antiserum. In the lower panel, the mem-
rane was reprobed with MAb AB1.1 to the VV D8L protein. The sizes
f molecular weight markers are shown in kDa.2X4 protein had an intermediate phenotype showing
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134 MATHEW ET AL.hat the rate of transport from the ER was delayed com-
ared with WT. However, after a 6-h chase, all of this
rotein was endoH resistant (data not shown) and so
ad been exported from the ER.
The subcellular location of the B5R-K2X2 and K2X4
roteins was analysed independently through indirect
mmunofluorescence using human protein disulphide
somerase (PDI) and 1,4-galactosyltransferase (Gal trans)
s markers of the ER and TGN, respectively (Fig. 3). Cells
ere infected with either vB5R-K2X2 or vB5R-K2X4 and
hen stained with antibodies to B5R and PDI or to B5R
FIG. 3. Immunofluorescence showing the B5R-K2X2 protein in the E
ndirect immunofluorescence as described in Materials and Methods.
FIG. 2. Pulse-chase analysis. BS-C-1 cells were infected with the
ndicated viruses and pulse-labeled for 5 min at 6.5 h p.i. as described
n Materials and Methods. After immunoprecipitation with antibody to
he B5R protein and incubation with (1) or without (2) EndoH, the
amples were resolved by SDS–PAGE (12% gels). Autoradiographs of
he dried gels are shown. The positions of molecular weight markers
re shown.n panels C, D, G and H were infected with vB5R-K2X4. The insets in A and Bnd Gal trans. In vB5R-K2X4-infected cells, the B5R pro-
ein was concentrated within small punctate foci resem-
ling disseminated VV particles (Figs. 3C and 3G) and
erinuclear structures that also contained the TGN
arker gal Trans (Figs. 3G and 3H). In contrast, in cells
nfected with vB5R-K2X2, the B5R antigen showed a strik-
ngly different pattern that had an extensive reticular
istribution similar to that of PDI (Figs. 3A and 3B) and
as predominantly segregated from Gal trans-positive
embranes (compare Figs. 3E and 3F). Note also the
ronounced staining of the nuclear envelope (Figs. 3A
nd 3E). The distribution of B5R protein in vB5R-K2X4 and
B5R/TK-infected cells were indistinguishable (data not
hown). Thus the K2X2 motif functioned as anticipated,
nd the B5R-K2X2 protein was relocated to the ER.
Previous studies have shown that some B5R protein is
resent on the cell surface as well as on IEV, CEV, and
EV particles (Schmelz et al., 1994). The level of B5R
rotein on the surface of cells infected with vB5R/TK,
B5R-K2X2, and vB5R-K2X4 was assessed by flow cytom-
try after staining with MAb 19C2 (Fig. 4A). The levels of
5R protein detected on cells infected with vB5R/TK and
B5R-K2X4 were similar, but there was a significant re-
uction in B5R surface expression in vB5R-K2X2-infected
ells. Control experiments using an isotype-matched rat
Ab and vDB5R-infected cells confirmed the specificity
f staining (Figs. 4B and 4C).
rapping of IMV to form IEV
The formation of virus particles in vB5R-K2X2-infected
ells was examined next. Figure 3 shows that the num-
er of B5R-positive virions in cells infected with vB5R-
2X2 was reduced greatly compared with vB5R-K2X4
compare Figs. 3A and 3E with 3C and 3G). This sug-
ested that either IEV particles were not formed when
he B5R protein was retained in the ER or IEV particles
ere formed but these did not contain detectable levels
f B5R. These possibilities were addressed by confocal
nd electron microscopy.
lectron microscopy
To determine whether cells infected with vB5R-K2X2
roduced IEV particles, cells were fixed at 12 h p.i. and
rocessed for thin section transmission electron micros-
opy. In these cells, all stages of VV morphogenesis
ere evident, and IEV particles were formed (Figs. 5A
nd 5B). To determine whether the frequency of IEV
article formation was different in cells infected with
B5R-K2X2, vB5R-K2X4, and vB5R/TK, the number of virus
articles that were partially or completely enveloped was
C-1 cells were infected with the indicated viruses and processed for
hown in panels A, B, E, and F were infected with vB5R-K2X2, and cellsR. BS-
Cells sshow the reticular staining pattern at a higher magnification.
135TARGETING VACCINIA PROTEIN B5R TO THE ER
136 MATHEW ET AL.FIG. 3—Continued
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137TARGETING VACCINIA PROTEIN B5R TO THE ERxpressed as a percentage of the total number of parti-
les counted. The percentage of IMV particles that
howed any wrapping (partial or complete) for vB5R-K2X2
22%, 59 of 273) and vB5R-K2X4 (34%, 106 of 305) was
lightly reduced or similar, respectively, to that for
B5R/TK (31%, 48 of 154) but much higher than that for
DB5R (1%, 2 of 157) (Mathew et al., 1998). However, the
ercentage of completely wrapped IEV particles was
ower for both vB5R-K2X2 (8%, 22 of 273) and vB5R-K2X4
13%, 41 of 305) compared with that for vB5R/TK (29%, 44
f 154). Therefore, either the relocation of the B5R protein
o the ER or the addition of extra amino acids at its
-terminus reduced the efficiency of IEV formation. Nev-
rtheless, significant numbers of IEV were formed by
B5R-K2X2 and vB5R-K2X4. However, an interesting prop-
rty of vB5R-K2X2 morphogenesis was the higher-than-
sual frequency of clusters of IEV and CEV particles that
ere contained within a single outer envelope (Figs. 5C
nd 5D). For vB5R-K2X2, there were 21 examples of this
inside or outside the cell), whereas for vB5R-K2X4 and
B5R/TK, only 2 examples were seen.
o IEV particles made by vB5R-K2X2 contain B5R?
To address this question, infected cells were stained
ith MAbs against the D8L and B5R proteins or against
he D8L and F13L proteins and were analysed by immu-
ofluorescence and confocal microscopy. The D8L pro-
ein is present on all virions (IMV, IEV, CEV, and EEV), and
o its detection served as a measure of the total number
f virus particles. On the other hand, the B5R and F13L
roteins, being specific for IEV, CEV, and EEV, would
etect only particles that had been wrapped by intracel-
ular membranes that contained these antigens. Figure 6
hows that the number of D8L-positive virions was sim-
lar in cells infected with either vB5R-K2X2 or vB5R/TK, but
he number of B5R- or F13L-positive structures differed.
n vB5R/TK-infected cells, the percentage of total parti-
les that were B5R positive (46.7 6 3.2%) or F13L positive
49.8 6 4.2%) were similar, but in vB5R-K2X2-infected
ells, the proportion of B5R-positive particles was much
ower (4.3 6 1.3%) than F13L-positive virions (31.6 6
.7%). This result, taken together with the reduced num-
er of B5R-positive structures seen in vB5R-K2X2-infected
ells compared with vB5R-K2X4-infected cells (Fig. 3), and
he detection of IEV particles by electron microscopy
Fig. 4), indicated that IEV particles were formed when
he majority of B5R was present in the ER, rather than
GN.
ormation of actin tails
To determine whether actin tails were being made in
B5R-K2X2-infected cells, the cells were stained with tet-
amethylrhodamine B isothiocyanate–phalloidin to detect
olymerised actin and costained with a MAb to B5R (Fig.
). No actin tails are evident in the vB5R-K2X2-infected pell shown in Fig. 7B, although occasionally one or more
ctin tail was seen in some other vB5R-K2X2-infected
ells, particularly late during infection (not shown). In
ontrast, actin tails were detected easily after infection
ith vB5R-K2X4 (Fig. 7D). It appears, therefore, that al-
hough the loss of B5R from IEV virions does not prevent
heir formation, it does restrict their ability to induce actin
ail formation.
laque size
The size of plaques formed by vB5R-K2X2 and vB5R-
2X4 on BS-C-1 cells is shown in Fig. 8 compared with
T, vDB5R, and vB5R/TK. Plaques formed by vB5R-K2X4
ere indistinguishable from WT or vB5R/TK, but those
ormed by vB5R-K2X2 were intermediate between WT and
DB5R. The reduced plaque size of vB5R-K2X2 is consis-
ent with the reduced number of actin tails produced by
his virus. The fact that plaques are larger than those
ade by vDB5R is consistent with a few actin tails still
eing made. Plaques formed by all viruses under liquid
verlay did not form comets (data not shown), suggesting
hat enhanced levels of EEV were not produced.
roduction of intracellular and extracellular virus
The amount of infectious intracellular and extracellular
irus produced by vB5R-K2X2 and vB5R-K2X4 was deter-
ined after infection of RK13 cells at 1 PFU/cell (Fig. 9A). The
nfectious titres at each location were very similar for all
iruses, and as usual with the WR strain of VV, the great
ajority of infectious progeny was intracellular. To confirm
hat the extracellular virus was EEV and not IMV that had
een released from infected cells on lysis, the sensitivity of
he extracellular virus to neutralisation by an IMV-specific
Ab was investigated (Fig. 9B). In all cases the majority of
he extracellular virus was resistant to neutralisation,
hereas the same concentration of this antibody neu-
ralised 86–92% of purified IMV (data not shown). Interest-
ngly, the EEV released from vB5R-K2X2-infected cells
howed the greatest resistance to neutralisation (95%),
omparable to the resistance of the EEV made by vDB5R
Mathew et al., 1998) (and data not shown).
As an independent method to determine whether the
xtracellular virus detected was IMV or EEV, virus re-
eased from [35S]methionine- and [35S]cysteine-labeled
nfected cells was analysed by CsCl density gradient
entrifugation (Parkinson and Smith, 1994). Analysis of
he virus released from 1 3 107 RK13 cells infected with
B5R-K2X2 or vB5R-K2X4 showed that virtually all (.95%)
f the virus present in the culture supernatant had EEV
ensity (data not shown). This observation is not incon-
istent with the fact that up to one third of the extracel-
ular virus could be neutralised by the IMV antibody,
ecause EEV with a damaged outer envelope can retain
EV density and be neutralised by IMV antibody (Vander-
lasschen and Smith, 1997).
Ei
f
i
(
p
a
a
u
f
a
(
i
l
a
e
n
b
p
v
K
D
[
s
f
B
s
c
o
a
w
v
E
b
s
K
l
r
t
i
p
w
c
m
f
p
f
m
n
w
d
n
p
c
c
(
s
v
B
(
n
i
138 MATHEW ET AL.EV from vB5R-K2X2-infected cells lacks B5R
To determine whether EEV released from vB5R-K2X2-
nfected cells contained B5R, virus was concentrated
rom the supernatant of infected cells and analysed by
FIG. 4. Flow cytometry. TK2143B cells were infected with the indi-
ated viruses at 5 PFU/cell. At 12 h p.i. the level of B5R protein on the
ell surface was determined as described in Materials and Methods.
A) Cells were infected with vB5R-K2X2, vB5R-K2X4, or vB5R/TK and then
tained with rat MAb 19C2 against B5R. (B) Cells were infected with
DB5R, WT, or vB5R/TK and then stained with rat MAb 19C2 against
5R. (C) Cells were infected with WT virus and stained with MAb 19C2
continuous line) or an isotype-matched rat MAb OX11(dotted line). The
umber of cells is shown on the y axis, and the log10 fluorescent
ntensity is shown on the x axis.mmunoblotting using polyclonal antibody against B5RFig. 10). The amount of soluble, 35-kDa B5R that was
resent in the culture supernatant and the relative
mount of B5R in infected cells were also determined. As
control, MAb AB1.1 against the IMV protein D8L was
sed to reprobe the nitrocellulose membrane. Cells in-
ected with vB5R/TK and vB5R-K2X4 produced similar
mounts of B5R in infected cells (C), extracellular virions
V), and culture supernatant (S). In contrast, vB5R-K2X2-
nfected cells produced no detectable B5R in extracellu-
ar virions or the culture supernatant but had similar
mounts of cell-associated B5R. The lack of B5R in the
xtracellular virions was not due to a reduction in the
umber of virus particles because when duplicate mem-
ranes were probed with MAb directed against the D8L
rotein, similar amounts of D8L antigen were detected in
irus (V) released after infection with vB5R-K2X2, vB5R-
2X4, or vB5R/TK (lower panel). The similar amounts of
8L antigen (Fig. 10), infectious virus (Fig. 9), and
35S]methionine- and [35S]cysteine-labeled virus (data not
hown) made by these viruses, but the absence of B5R
rom the vB5R-K2X2 virions indicates that virions lacking
5R have normal infectivity.
Last, the absence of the 35-kDa form of B5R in the
upernatant of vB5R-K2X2-infected cells indicates that
leavage of the 42-kDa precursor into the 35-kDa form
ccurs in a post-ER compartment.
DISCUSSION
A recombinant VV that expresses a B5R protein with
n ER retrieval sequence (vB5R-K2X2) at its C-terminus
as constructed and analysed. The B5R protein made by
B5R-K2X2 was shown to be located predominantly in the
R, rather than in the TGN as for the B5R protein made
y WT virus and the virus with an inactive ER retrieval
equence (vB5R-K2X4) at the C-terminus of B5R. vB5R-
2X2 formed normal amounts of IMV and EEV, and slightly
ower amounts of IEV, but the B5R-K2X2 protein was
educed greatly in IEV and not detected in EEV. Despite
his, the EEV had normal infectivity. Few actin tails were
nduced on IEV particles, and consistent with this, the
laque size of the vB5R-K2X2 was reduced compared
ith WT but slightly larger than vDB5R.
At the outset of this work, we considered that the
onsequence of redirecting the B5R protein to the ER
ight be that either IMV particles would be wrapped
rom that location to form IEV or wrapping would not take
lace. However, it was found that wrapping took place
rom the TGN, but the B5R protein was not detected on
ost wrapped particles (immunofluorescence) and was
ot detected at all on EEV by immunoblotting. This result
as surprising because two groups had shown indepen-
ently that a mutant virus lacking the B5R protein made
ormal IMV, but the wrapping of IMV to IEV did not take
lace (Engelstad and Smith, 1993; Wolffe et al., 1993).So how is the wrapping observed here explained? One
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139TARGETING VACCINIA PROTEIN B5R TO THE ERossibility is that a small amount of B5R is present in the
GN and that this is sufficient to initiate the wrapping
rocess. In support of this possibility, the K2X2 motif used is
retrieval sequence rather than a retention sequence
Jackson et al., 1990; 1993), so some B5R might be present
n the TGN transiently before being retrieved to the ER or
ncorporated into IEV. In fact a small fraction of the IEV
articles did contain B5R (as detected by immunofluores-
ence), although it is unclear from this analysis how much
5R was incorporated compared with WT. Perhaps IEV
FIG. 5. Electron microscopy. HeLa cells were infected with vB5R-K
ethods. Panel A shows a typical virus factory, panel B shows two IEV
he same outer membranes, and panel D shows a cluster of CEV part
ail. Bar in panel A 5 500 nm, bar in panels B–D 5 200 nm.ontaining only a small fraction of the amount of B5R found Mn WT IEV might still be revealed by this technique. Cer-
ainly the level was low because B5R was not detected in
EV by immunoblotting. The detection of B5R on some IEV
articles by immunofluorescence but not on EEV by immu-
oblotting might represent different sensitivities of the tech-
iques. Alternatively, enveloped virus containing B5R might
e retained on the cell surface, whereas virions lacking B5R
ight be released; in this regard, it is noteworthy that
iruses with one or more of the B5R SCR domains deleted
eleased enhanced levels of EEV (Herrera et al., 1998;
d processed for electron microscopy as described in Materials and
les, panel C shows the presence of several IMV particles wrapped by
closed within the same outer envelope and associated with an actin2X2 an
partic
icles enathew et al., 1998).
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140 MATHEW ET AL.An alternative possibility to explain the IMV wrapping
s that the normal interactions that exist between differ-
nt EEV proteins (Ro¨ttger et al., 1999) are established in
he ER and that B5R is important for initiating the forma-
ion of these complexes. However, once these com-
lexes are transported to the Golgi complex, the B5R-
2X2 protein is stripped from them by the ER retrieval
otif and returned to the ER. Ultimately, the complexes
re deficient in B5R, but B5R had an important role in
heir formation. This would contrast with the situation in
DB5R-infected cells, in which the complexes might
ever become established and hence wrapping is inhib-
ted.
In vB5R-K2X2-infected cells, the EEV proteins in TGN
embranes are sufficient to enable wrapping of IMV to
EV, but actin tail formation was reduced greatly. This
ndicates differing requirements for these two processes,
s noted with other EEV mutants; for instance, the DA36R
utant (Parkinson and Smith, 1994; Sanderson et al.,
998; Wolffe et al., 1998) and the B5R mutants lacking
CR domains (Herrera et al., 1998; Mathew et al., 1998)
re able to wrap IMV normally but unable to initiate actin
ail formation. The intermediate plaque size of vB5R-K2X2
as consistent with its reduced ability to initiate actin tail
ormation, because actin tails are considered important
or cell-to-cell spread of virus. vB5R-K2X2 made more
ctin tails than vDB5R but less than WT; hence the
laque size was intermediate between these two vi-
uses.
The amount, buoyant density, and infectivity of EEV
FIG. 6. Bar graphs showing the percentage of intracellular virus
articles that were positive for the B5R or F13L proteins determined by
ouble immunofluorescent staining and confocal microscopy. BS-C-1
ells were grown on glass coverslips and infected with vB5R-K2X2 or
B5R/TK. At 9 h p.i. two coverslips were removed from the same culture
ish and processed for fluorescent microscopy as described in Mate-
ials and Methods. One coverslip was stained with MAb AB1.1 against
8L and MAb 19C2 against B5R, whereas the second coverslip was
tained with MAb AB1.1 and MAb 15B6 against F13L. The numbers of
irions stained with D8L, B5R, and F13L were recorded from confocal
mages of cells. Bars show the mean number of particles stained by
ach antibody 6S.E.M. (n 5 7). Lines underneath the graph show data
erived from cells on the same coverslip.roduced by vB5R-K2X2 were indistinguishable from WT Tespite the few actin tails and the absence of B5R from
EV. It is unclear how normal amounts of EEV are made
hen actin tail formation is reduced greatly, but several
ther EEV mutants make normal or enhanced levels of
EV and have decreased formation of actin tails (McIn-
osh and Smith, 1996; Wolffe et al., 1997; Herrera et al.,
998; Mathew et al., 1998; Roper et al., 1998; Sanderson
t al., 1998). There is, therefore, an actin-independent
athway for EEV formation. This might involve the move-
ent of IEV particles to the surface in an actin-indepen-
ent manner or the direct budding of IMV through the
lasma membrane as observed with the IHD-W strain of
V (Tsutsui, 1983). The electron microscopy of vB5R-
2X2-infected cells did not provide evidence for the latter,
lthough there were more incompletely wrapped IMV
articles and an increased number of virions (IEV or
EV) contained within a single outer envelope. A possi-
le explanation for this phenotype might be that there is
ess efficient interaction between vB5R-K2X2 IMV parti-
les and wrapping membranes compared with WT IMV.
onsequently, vB5R-K2X2 IMV particles accumulate be-
ore wrapping, and subsequently multiple virions are
rapped in the same membranes. The normal infectivity
f EEV lacking B5R indicated that B5R is not required for
EV infectivity despite B5R being reported to be a target
or antibodies that neutralise EEV infectivity (Galmiche et
l., 1999).
In conclusion, we report here the effects of redirecting
he B5R protein from the TGN to the ER on VV morpho-
enesis and dissemination. Despite the location of the
5R in the ER, IMV particles were wrapped normally to
orm IEV. However, the great majority of IEV particles
ere deficient in B5R and did not induce actin tails so
hat the plaque size was reduced. However, the forma-
ion of infectious EEV was not reduced, demonstrating
hat the EEV particles can infect new cells in the absence
f B5R.
MATERIALS AND METHODS
ells and viruses
TK2143B, RK13, HeLa, and BS-C-1 cells were grown in
ulbecco’s modified Eagle’s medium in 10% FBS. VV
train Western Reserve (WR) and the recombinants de-
ived from WR, vDB5R (Engelstad and Smith, 1993), and
B5R/TK (Mathew et al., 1998) have been described pre-
iously.
lasmids
Plasmid pEM9 contains the 59 end of the B5R gene
including the B5R promoter) inserted within the VV thy-
idine kinase (TK) gene (Mathew et al., 1998) and was
sed to construct plasmids encoding the entire B5R ORF
used at the C-terminus to either the K2X2 or K2X4 motifs.
he 39 end of the B5R gene encoding the 180 C-terminal
i
FIG. 7. Detection of actin tails in virus-infected cells. BS-C-1 cells were infected with the indicated viruses and then processed for doublemmunofluorescent microscopy as described in Materials and Methods.
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142 MATHEW ET AL.mino acids fused to the K2X2 or K2X4 motifs was ampli-
ied by PCR using plasmid pSTH4 as the template
Howard, 1991) and oligonucleotides TACGAAGTGAAT-
CCACCAT (forward primer) and either CCCGAATTCT-
AgaggctcttcttCGGTAGCAATTTATGGAACTT or CCC-
AATTCTTAgagagcgaggctcttcttCGGTAGCAATTTATGG-
ACTT as reverse primers for the K2X2 or K2X4 motifs,
espectively. Underlined, bold, or lowercase nucleotides
epresent the EcoRI site, translational termination codon,
r K2X2 or K2X4 motifs, respectively. PCR fragments of 706
nd 712 bp were isolated, digested with EcoRI, and
loned into pEM9 that had been digested with EcoRI.
he resultants plasmids, pEM16 and pEM17, contained
he entire B5R gene with either KKSL (B5R-K2X2) or KK-
LAL (B5R-K2X4) fused to the C-terminus inserted within
he VV TK gene.
onstruction of recombinant VVs
Plasmids pEM16 or pEM17 were transfected into
DB5R-infected cells, and TK negative recombinant vi-
2
FIG. 8. Plaque sizes produced by different viruses. Monolayers of BS
nd incubated in MEM containing 1.5% carboxymethyl cellulose and 2.
ith crystal violet.uses were isolated by plaque assay on TK 143 cells as oescribed previously (Mathew et al., 1998). These vi-
uses were plaque purified three times, amplified, and
amed vB5R-K2X2 and vB5R-K2X4, respectively.
mmunofluorescence
BS-C-1 cells were infected at 1 PFU/cell and pro-
essed for indirect immunofluorescence at 14 h p.i. (un-
ess stated otherwise) as described previously (Sander-
on et al., 1998). Mouse MAb AB1.1 directed against the
V D8L gene product (diluted 1:300) (Parkinson and
mith, 1994), rabbit polyclonal antibody against bovine
al trans (diluted 1:100) (Lopez et al., 1991), or mouse
Ab ID3 directed against PDI (hybridoma culture super-
atant diluted 1:100) (Vaux et al., 1990; Fricker et al.,
997), and rat MAbs against VV B5R (19C2, hybridoma
ulture supernatant diluted 1:8) (Hiller and Weber, 1985)
nd VV F13L (15B6, hybridoma culture supernatant di-
uted 1:5) (Hiller and Weber, 1985) were used as primary
ntibodies. Bound antibodies were detected with fluo-
escein B isothiocyanate-conjugated goat anti-mouse Ig
ells were infected with approximately 50 PFU of the indicated viruses
. Five days later the overlay was removed, and the cells were stained-C-1 c
5% FBSr rhodamine-conjugated donkey anti-rat or anti-rabbit Ig
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143TARGETING VACCINIA PROTEIN B5R TO THE ERboth diluted 1:50) (Jackson Laboratories). Filamentous
ctin was detected by direct staining with tetramethyl-
hodamine B isothiocyanate–phalloidin (Sigma, Poole,
K). Images of a single focal plane were collected using
Bio-Rad MRC 1024 laser scanning confocal micro-
cope and were processed with Adobe TM Photoshop
oftware.
low cytometry
TK2143 cells were infected at 5 PFU/cell. At 12 h p.i.
he cells were washed in PBS, incubated in 2 mM EDTA
n PBS for 20 min at 37°C, and lifted from the Petri dish
y pipetting. Cells were incubated for 1.5 h on ice with
FIG. 9. Growth of VVs in cell culture. (A) RK13 cells were infected with
he indicated viruses at 1 PFU/cell. At 24 h p.i. the titre of virus present
n the infected cells (hatched bars) and the culture supernatant (stip-
led bars) was determined by plaque assay on BS-C-1 cells as de-
cribed in Materials and Methods. (B) Percentage of infectivity in the
ell supernatant that is resistant to neutralisation by MAb 5B4/2F2.ndiluted tissue culture supernatant from either rat hy- pridoma 19C2 (anti-B5R) or OX11 (an isotype-matched rat
Ab) (Hunt and Fowler, 1981). Cells were washed with
BS containing 10% heat-inactivated FBS and then incu-
ated for 2 h at 4°C with fluorescein B isothiocyanate-
onjugated sheep anti-rat IgG (diluted 1:100) (Serotech).
fter further washing in PBS containing 10% heat-inacti-
ated FBS, the cells were fixed in PBS containing 4%
araformaldehyde and analysed by flow cytometry as
escribed previously (Vanderplasschen and Smith,
997).
mmunoblotting
BS-C-1 cells were infected at 10 PFU/cell in the pres-
nce or absence of tunicamycin (10 mg/ml). At 16 h p.i.,
he cells were washed in PBS, scraped from the dish,
ollected by centrifugation (2000 rpm, 10 min, 4°C), and
issolved in RIPA buffer minus SDS (150 mM NaCl, 1%
onidet P-40, 0.5% sodium deoxycholate, 50 mM Tris–
Cl, pH 8). Protein samples were then mixed with protein
oading buffer, resolved by SDS–PAGE (12% gel), and
ransferred to nitrocellulose membranes. Membranes
ere incubated with rabbit polyclonal antibody against
he B5R protein (Engelstad et al., 1992) (diluted 1:2000) or
ith mouse MAb AB1.1 against VV D8L protein (Parkin-
on and Smith, 1994) (diluted 1:2000), and bound anti-
ody was detected by incubation with anti-rabbit or anti-
ouse horseradish peroxidase-conjugated antibodies
diluted 1:2000) (Sigma, Dorset, UK) followed by chemi-
uminescence reagents (Amersham) as directed by the
anufacturer. When membranes were to be reprobed
ith a second antibody they were first stripped by incu-
ation in 100 mM 2b-mercaptoethanol, 2% SDS, and 62.5
M Tris–HCl, pH 6.7 (50°C, 30 min with gentle agitation),
nd then washed in PBS containing 0.1% Tween 20.
lectron microscopy
HeLa cells were infected at 5 PFU/cell for 2 h at 37°C.
nbound virus was then washed away, and the cells
ere incubated at 37°C in MEM containing 2.5% FBS for
0 h before being washed in ice-cold PBS and fixed in
.5% glutaraldehyde in 200 mM sodium cacodylate (pH
.4) for 30 min at room temperature. After fixation, cells
ere washed in 200 mM sodium cacodylate and post-
ixed in 1% osmium tetroxide and 1.5% potassium ferro-
yanide for 60 min at room temperature. Samples were
hen washed in water, incubated overnight at 4°C in
g21-uranyl acetate, washed again in water, dehydrated
n ethanol, and flat-embedded in Epon. Sections were cut
arallel to the surface of the dish, lead citrate was added
s a contrast agent, and the sections were examined on
Zeiss Omega EM 912 electron microscope (LEO Elec-
ron Microscope Ltd.) equipped with a Proscan-cooled,
CD camera (1024 3 1024 pixels) and a Dage-MTI SIT
6 low-level light camera. The captured images were
rocessed using Adobe Photoshop TM software.
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144 MATHEW ET AL.mmunoprecipitation and pulse-chase analysis
BS-C-1 cells were infected at 5 PFU/cell. At 6 h p.i., the
ells were washed with MEM lacking methionine and
ysteine (prewarmed to 37°C) and incubated in the same
edium for 30 min. Cells were then labeled metaboli-
ally with the same medium supplemented with 25 mCi
f Promix (a mixture of [35S]methionine and [35S]cysteine,
000 Ci/mmol, Amersham, UK) and 25 mCi of [35S]cys-
eine (600 Ci/mmol, New England Nuclear) for 5 min.
ells were harvested immediately or chased for 20, 40,
0, or 80 min in MEM supplemented with 2 mM cysteine
nd methionine. At the time of harvest, cells were
ashed on ice with ice-cold PBS and lysed in RIPA buffer
inus SDS. The lysates were centrifuged for 10 min at
000 rpm in a Beckman GPR centrifuge, and then SDS
as added to the supernatant to a final concentration of
.1%. Samples were incubated with rabbit polyclonal
ntibody to the VV B5R protein (Engelstad et al., 1992).
mmune complexes were immunoprecipitated with pro-
ein A-conjugated Sepharose beads, and the immuno-
recipitates were incubated for 3 h at 37°C in the pres-
nce or absence of 1000 units of EndoHf (New England
iolabs). Samples were resolved by SDS–PAGE (12%
el), and the dried gel was analysed by autoradiography.
nalysis of virus growth properties
RK13 cells were infected at 1 PFU/cell, and after 2 h the
FIG. 10. Immunoblots showing the B5R and D8L proteins present in i
S). RK13 cells were infected at 10 PFU/cell and cultured in MEM witho
pm, 10 min, 4°C) to pellet detached cells and then at high speed (14,
ulture supernatant was precipitated by the addition of trichloroacetic a
ere scraped from the cell monolayer into PBS and recovered by centri
rom low-speed centrifugation of the culture supernatant and dissolved
mmunoblotted as described in Materials and Methods. To obtain comp
rom 1 3 106 cells (V), or cell lysates from 2 3 104 cells were loaded o
ower panel shows the same membrane reprobed with anti-D8L MAbells were washed with MEM containing 2.5% FBS (pre- narmed to 37°C) and then incubated in the same me-
ium. At 24 h p.i. the culture supernatant was collected
nd centrifuged to remove detached cells (2000 rpm, 10
in, 4°C). The virus present in the clarified supernatant
as titrated by plaque assay on BS-C-1 cells before or
fter incubation for 1 h at 4°C with MAb 5B4/2F2 directed
gainst the IMV surface protein A27L (Czerny and Mah-
el, 1990). MAb was added to the samples after they had
een diluted to approximately 200 infectious particles
determined from prior pilot experiments) per unit volume
o that the ratio of MAb to infectious virus particles in the
est sample was constant. This concentration of MAb
as shown to neutralise 86–92% of purified IMV particles
data not shown). The titre of cell-associated virus was
etermined by scraping the infected cells from the dish
nto PBS and collecting the cells through centrifugation
2000 rpm, 10 min, 4°C). The cell pellet was combined
ith the pellet obtained during centrifugation of the cul-
ure supernatant, resuspended in PBS, frozen and
hawed three times, and sonicated, and then the virus
nfectivity was determined by plaque assay on BS-C-1
ells.
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